Mexico - Delayed Quote MXN
Atossa Therapeutics, Inc. (ATOS.MX)
15.50
+2.50
+(19.23%)
At close: April 24 at 12:18:44 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATOS.MX | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 4/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/12/2024 |
Related Tickers
GNFT Genfit S.A.
3.6700
-2.65%
FBRX Forte Biosciences, Inc.
6.96
+15.04%
ENVB Enveric Biosciences, Inc.
1.3348
+3.47%
KALA KALA BIO, Inc.
3.3000
+5.77%
BLUE bluebird bio, Inc.
4.1600
+1.71%
PHIO Phio Pharmaceuticals Corp.
2.2300
+9.31%
CAPR Capricor Therapeutics, Inc.
13.28
+0.99%
VXRT Vaxart, Inc.
0.3600
+4.74%
INO Inovio Pharmaceuticals, Inc.
1.9200
+2.67%
PSTV Plus Therapeutics, Inc.
0.8427
-14.32%